Încărcări by Putu Surya Sujana

2019 ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes

Cardiovascular Involvement in COVID-19- What Sequelae Should We Expect?

Gagal Jantung Notes

Dyspnea, Orthopnea, And Paroxysmal Nocturnal Dyspnea

https-::doi.org:10.1089:jmf.2008.1250

Effectiveness and Safety of Concurrent Beta-blockers and Inhaled Bronchodilators in COPD With Cardiovascular Comorbidities

Exercise Training and Cardiac Rehabilitation in COVID-19 Patients With Cardiovascular Complications- State of Art

RESPIRO Imunopatogenesis Corona Virus Disease 19 (COVID-19)

RESPIRO Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

RESPIRO Improving the Understanding of Immunopathogenesis of Lymphopenia as a Correlate of SARS-CoV-2 Infection Risk and Disease Progression in African Patients

RESPIRO Immunopathogenesis of COVID-19 and Early Immunomodulators

RESPIRO Immunological Basis of COVID-19

RESPIRO Immune Response to SARS-CoV-2 and Mechanisms of Immunopathological Changes in COVID-19

RESPIRO Immune Response in SARS-CoV-2 Infection

RESPIRO COVID-19 Infection Through Complement-targeted Immunotherapy

RESPIRO BAB II Usulan Penelitian

Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

SARS-CoV-2eA Tough Opponent for the Immune System

Imunopatogenesis Corona Virus Disease 19 (COVID-19)

Improving the Understanding of Immunopathogenesis of Lymphopenia as a Correlate of SARS-CoV-2 Infection Risk and Disease Progression in African Patients

Immunopathogenesis of COVID-19 and Early Immunomodulators

Immunological Basis of COVID-19

Immune Response in SARS-CoV-2 Infection

Korelasi QSOFA, NLR, Dan Rasio SpO2:FiO2 Terhadap Kadar Prokalsitonin Untuk Memprediksi Luaran Pasien Covid19 Dengan Koinfeksi Baterial Yang Mengalami Sepsis Di RSUP Sanglah

Immune Response to SARS-CoV-2 and Mechanisms of Immunopathological Changes in COVID-19

respiro A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19)- A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China

131-560-1-PB

52-46-PB

1752-5420-2-PB

1512-7963-1-PB

525-2595-1-PB

525-2595-1-PB (1)

52-46-PB respiro

17. BAB VII respiro

11. BAB I respiro

12603-44185-1-SM

respiro 3

4872-1-7523-1-10-20130301

3748-10569-1-PB

2019冠状病毒病患者临床特征对重症化的预测作用

1752-5420-2-PB

1512-7963-1-PB

525-2595-1-PB

74-316-7-PB (1)

74-316-7-PB

58-66-9-PB

89-317-5-PB

majalah respiro 2

58-66-9-PB (2)